It was during the 70s when Bayer’s pharmaceuticals’ sales began to ... its own name and using its own Bayer Cross corporate logo. This was under the leadership of Dr Manfred Schneider, who ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...

The Bundesliga title race could take a definitive turn this weekend as Bayer Leverkusen welcome Bayern Munich to BayArena on Saturday. Xabi Alonso's men are second in the standings with 46 points ...

DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...

Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor ...

Bayer Leverkusen is set to host Bayern Munich in a sensational Bundesliga clash at the BayArena on February 15. Leverkusen, the defending champions, are currently eight points behind league ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...

Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sports Mole previews Saturday's Bundesliga clash between Bayer Leverkusen and Bayern Munich, including predictions, team news and possible lineups. Leverkusen were held to a 0-0 draw by Wolfsburg ...

The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like diabetes, hypertension, and aging, is driving the demand for artificial ...